Morgan Stanley Sees the Moderna (MRNA) Booster Opportunity as More Sustainable, Raising Dose Ests and PT to $215
Tweet Send to a Friend
(Updated - February 18, 2021 6:45 AM EST)Morgan Stanley analyst Matthew Harrison raised the price target on Moderna (NASDAQ: MRNA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
